Feinberg has maintained its standing among the best research-oriented medical schools in the country, placing 17th in the latest U.S. News & World Report rankings.
Testosterone treatment in older men reduced anemia but did not improve cognitive function, and was associated with a significant increase in arterial plaque, according to Northwestern Medicine clinical trials.
A JAMA study has found that hemoglobin A1C measurements — a biomarker frequently used to diagnose diabetes — may be less accurate in African-Americans with sickle cell trait.
A recent study assessed the barriers preventing individuals from participating in biobanking research projects, including concerns about informed consent and data sharing.
With evidence-based smartphone apps developed by our Center for Behavioral Intervention Technologies, mental healthcare is always within reach.
Revolutionary nanomaterials developed at Northwestern could make it possible to repair tissues and organs spanning from bone and cartilage to muscle and brain tissues.
A Northwestern Medicine study has established a new safety index for a common group of chemotherapy drugs, by using a stem cell model to screen such therapies for cardiotoxicity.
A recent study, published in the New England Journal of Medicine, found a newer left ventricular assist device performed at least as well as existing devices on the market for patients with advanced heart failure.
A phase 1 clinical trial of venetoclax and rituximab combination therapy was shown to be an effective chemo-free treatment option for patients with difficult-to-treat chronic lymphocytic leukemia.
A newly identified biomarker may predict treatment response in patients with chronic myelogenous leukemia, according to a Northwestern Medicine study.